BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

923 related articles for article (PubMed ID: 18758412)

  • 21. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
    El-Khatib M; Duncan HJ; Kant KS
    Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
    Malyszko J; Malyszko JS; Mysliwiec M
    Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation.
    Kuragano T; Shimonaka Y; Kida A; Furuta M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T
    Am J Nephrol; 2010; 31(6):534-40. PubMed ID: 20484891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio-renal anemia syndrome.
    Kato A
    Future Cardiol; 2010 Nov; 6(6):769-71. PubMed ID: 21142632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum pro-hepcidin levels and relationships with iron parameters in healthy preterm and term newborns.
    Tiker F; Celik B; Tarcan A; Kilicdag H; Ozbek N; Gurakan B
    Pediatr Hematol Oncol; 2006 Jun; 23(4):293-7. PubMed ID: 16621770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?
    Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Mysliwiec M
    Am J Nephrol; 2005; 25(6):586-90. PubMed ID: 16254410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
    Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
    Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-6 is an independent risk factor for resistance to erythropoiesis-stimulating agents in hemodialysis patients without iron deficiency.
    Won HS; Kim HG; Yun YS; Jeon EK; Ko YH; Kim YS; Kim YO; Yoon SA
    Hemodial Int; 2012 Jan; 16(1):31-7. PubMed ID: 22284696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
    Malyszko J; Malyszko JS; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of hepcidin in iron homeostasis and anemia in hemodialysis patients.
    Eleftheriadis T; Liakopoulos V; Antoniadi G; Kartsios C; Stefanidis I
    Semin Dial; 2009; 22(1):70-7. PubMed ID: 19250447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro-hepcidin and iron metabolism parameters in multi-time blood donors.
    Boinska J; Zekanowska E; Kwapisz J
    Int J Lab Hematol; 2010 Oct; 32(5):483-90. PubMed ID: 19968722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of iron deficiency in erythropoietin sensitivity in dialysis patients with elevated C-reactive protein].
    Martone M; Zanchi R; Panzetta G
    G Ital Nefrol; 2003; 20(1):31-7. PubMed ID: 12647284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children.
    Aeberli I; Hurrell RF; Zimmermann MB
    Int J Obes (Lond); 2009 Oct; 33(10):1111-7. PubMed ID: 19636315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal role of hepcidin and iron homeostasis in full-term intrauterine growth-restricted infants.
    Briana DD; Boutsikou T; Baka S; Boutsikou M; Stamati L; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
    Eur J Haematol; 2013 Jan; 90(1):37-44. PubMed ID: 23110713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
    J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI).
    Sasu BJ; Li H; Rose MJ; Arvedson TL; Doellgast G; Molineux G
    Blood Cells Mol Dis; 2010 Oct; 45(3):238-45. PubMed ID: 20800515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S; Safárová R; Horácková M; Herink J; Rychlík I; Bahbouh R; Půtová I
    Cas Lek Cesk; 2001 Apr; 140(7):209-13. PubMed ID: 11374225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma prohepcidin positively correlates with hematocrit in chronic hemodialysis patients.
    Hsu SP; Chiang CK; Chien CT; Hung KY
    Blood Purif; 2006; 24(3):311-6. PubMed ID: 16479095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.